N-heterocycle substituted tryptamine derivatives and methods of using
Grant
US12577232B2
Kind: B2
Mar 17, 2026
Assignee
Enveric Biosciences Canada Inc.
Inventors
David James Press, Glynnis Elizabeth Jensen, Kaveh Matinkhoo, Jessica Bik-Jing Lee, Jillian M. Hagel, Peter J. Facchini
Abstract
Disclosed are novel N-heterocycle-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
CPC Classifications
C07D 403/04
C07D 209/16
A61K 31/4045
A61K 31/496
A61K 31/5377
Filing Date
2025-05-29
Application No.
19222062
Claims
29